Parkinson’s Disease With Neurogenic Orthostatic Hypotension
PARKINSON’S DZ WITH IDIOPATHIC ORTHOSTATIC HYPOTENSION
Lundbeck NOH 402 RESTORE: A clinical study of patients with Parkinson’s Disease with symptomatic neuRogenic orthostatic hypotEnsion to assess Sustained effecTs Of dRoxidopa thErapy
- PI: ANDREA HALLER, MD
- CONTACT MINDY
- Duration 36 week study
- Phase 4 study
KEY INCLUSION CRITERIA
- *Age 18 and older
- *Orthostatic hypotension with PD, MSA or PAF
- *Drop of 20 mmHg in SBP .
KEY EXCLUSION CRITERIA
- Alcohol or drug abuse
- BP systolic > 180 diastolic > 110
- Hx of MI or stroke within 2 years.